A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2196156)

Published in J Exp Med on March 03, 1997

Authors

M Falcone1, B R Bloom

Author Affiliations

1: Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Articles citing this

Relation between objective measures of atopy and myocardial infarction in the United States. J Allergy Clin Immunol (2012) 1.98

Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice. Hepatology (2013) 1.78

Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest (2001) 1.66

Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol (2001) 1.52

Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med (2000) 1.14

Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J Exp Med (1997) 1.04

Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergy. J Exp Med (1998) 1.00

Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model. Clin Cancer Res (2009) 0.98

MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. J Clin Invest (2015) 0.97

Fms-like tyrosine kinase 3 ligand decreases T helper type 17 cells and suppressors of cytokine signaling proteins in the lung of house dust mite-sensitized and -challenged mice. Am J Respir Cell Mol Biol (2009) 0.96

Contrasting adaptive immune defenses and blood parasite prevalence in closely related Passer sparrows. Oecologia (2006) 0.93

Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy. J Exp Med (1999) 0.89

PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis. J Biol Chem (2009) 0.87

Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J Immunol (2011) 0.86

Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clin Exp Immunol (2014) 0.86

A tale of two STAT6 knock out mice in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 0.85

Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity? Front Immunol (2013) 0.84

Antigen inhibition of collagen-induced arthritis is associated with up-regulation of IL-4 mRNA and induction of Ox40 on T cells in draining lymph nodes. Clin Exp Immunol (2003) 0.81

Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 0.80

Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β. J Neuroimmunol (2012) 0.78

In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA). Clin Exp Immunol (1998) 0.78

Will the increasing prevalence of atopy have a favourable impact on rheumatoid arthritis? Ann Rheum Dis (1998) 0.77

Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis. Graefes Arch Clin Exp Ophthalmol (2009) 0.77

IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Regulatory T Cell Suppression To Restrain Experimental Allergic Encephalomyelitis. J Immunol (2017) 0.75

Articles cited by this

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69

The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med (1992) 7.80

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell (1995) 5.82

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today (1995) 5.32

Molecular mimicry and autoimmune disease. Cell (1987) 5.31

Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell (1993) 4.59

High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell (1994) 4.34

Induction of TH1 and TH2 immunity in neonatal mice. Science (1996) 4.25

Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol (1981) 3.96

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med (1995) 3.65

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med (1994) 2.70

Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A (1993) 2.65

Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Methods (1993) 2.62

Antigen-driven bystander suppression after oral administration of antigens. J Exp Med (1991) 2.62

A population-based study of multiple sclerosis in twins. N Engl J Med (1986) 2.59

Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1990) 2.23

Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci U S A (1992) 2.16

Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J Immunol (1992) 2.14

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.97

Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med (1989) 1.85

Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83

A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med (1990) 1.75

Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods (1990) 1.74

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today (1994) 1.73

Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol (1993) 1.57

Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J Exp Med (1995) 1.53

Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol (1993) 1.29

Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J Exp Med (1995) 1.23

Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J Neuroimmunol (1993) 1.12

Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol (1982) 1.05

IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T cells through an effect on antigen-presenting cells. J Immunol (1995) 0.96

Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis. J Autoimmun (1992) 0.95

Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant. Int Arch Allergy Appl Immunol (1985) 0.93

Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis. Eur J Immunol (1993) 0.92

Overview: infectious agents as etiologic triggers of autoimmune disease. Curr Top Microbiol Immunol (1989) 0.90

A 12-kDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis. Protection in the absence of shared T cell epitopes with encephalitogenic proteins. J Immunol (1995) 0.88

Infection and multiple sclerosis: a possible role for superantigens? Trends Microbiol (1994) 0.84

Heat shock proteins in autoimmune disease. From causative antigen to specific therapy? Experientia (1992) 0.80

Down-regulation of cell-surface CD4 co-receptor expression and modulation of experimental allergic encephalomyelitis. Int Immunol (1997) 0.78

Articles by these authors

(truncated to the top 100)

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56

Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12

Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08

Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74

Genetic systems for mycobacteria. Methods Enzymol (1991) 7.50

Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 7.46

Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature (1985) 6.54

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12

Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science (1993) 5.20

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature (1995) 5.04

CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03

An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02

Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc Natl Acad Sci U S A (1988) 4.90

Burden of disease--implications for future research. JAMA (2001) 4.75

Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61

Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1968) 4.57

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46

Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis (1983) 4.40

Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun (1995) 4.28

Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol (1999) 3.96

Transfer of delayed-type hypersensitivity. A critical review and experimental study in the guinea pig. Prog Allergy (1967) 3.86

Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature (1987) 3.83

Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun (1993) 3.80

An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A (1996) 3.78

Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1997) 3.67

In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun (1995) 3.56

Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature (1986) 3.51

In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol (1971) 3.49

Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39

Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun (2000) 3.39

IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29

Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A (2005) 3.29

Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity (1995) 3.12

Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol (1996) 2.98

Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun (1991) 2.77

Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72

Insertional mutagenesis and illegitimate recombination in mycobacteria. Proc Natl Acad Sci U S A (1991) 2.69

Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature (1984) 2.63

Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2000) 2.63

Studies on the migration inhibitory factor associated with delayed-type hypersensitivity: cytodynamics and specificity. Transplantation (1967) 2.52

An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol (1997) 2.46

Lepromin-induced suppressor cells in patients with leprosy. J Immunol (1979) 2.45

The evolving relation between humans and Mycobacterium tuberculosis. N Engl J Med (1998) 2.39

The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol (1978) 2.38

Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33

Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30

Genetic relationships among Mycobacterium leprae, Mycobacterium tuberculosis, and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence. Infect Immun (1989) 2.29

Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27

Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect Immun (1994) 2.26

Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21

A novel transposon trap for mycobacteria: isolation and characterization of IS1096. J Bacteriol (1991) 2.20

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A (2000) 2.20

Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (1995) 2.17

On the heterogeneity of murine natural killer cells. J Exp Med (1981) 2.15

A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J Exp Med (1970) 2.15

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A (1998) 2.13

Games parasites play: how parasites evade immune surveillance. Nature (1979) 2.04

Macrophage variants in oxygen metabolism. J Exp Med (1980) 2.04

Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae. Science (1996) 2.03

Migration inhibitory factor associated with delayed-type hypersensitivity. Fed Proc (1990) 2.02

Immunological unresponsiveness in leprosy. Immunol Rev (1984) 2.02

Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol (1980) 2.02

Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00

Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97

Interferon-gamma-induced transcriptional activation is mediated by protein kinase C. Proc Natl Acad Sci U S A (1988) 1.97

The major native proteins of the leprosy bacillus. J Biol Chem (1990) 1.96

Tuberculosis. Back to a frightening future. Nature (1992) 1.95

Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 1.94

A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med (1992) 1.93

Auxotrophic vaccines for tuberculosis. Nat Med (1996) 1.89

Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88

Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet (1992) 1.87

Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci U S A (1999) 1.84

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82

Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81

Immunological destruction of herpes simplex virus I infected cells. Nature (1974) 1.80

The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol (1981) 1.79

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci U S A (1993) 1.76

Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1996) 1.76

Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J Clin Microbiol (1996) 1.76

V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol (1995) 1.73

Oxygen metabolism in cloned macrophage cell lines: glucose dependence of superoxide production, metabolic and spectral analysis. J Immunol (1984) 1.73

Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature (1966) 1.68

Enumeration of activated thymus-derived lymphocytes by the virus plaque assay. Proc Natl Acad Sci U S A (1973) 1.67

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65

Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63

Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci U S A (1988) 1.62

Dissociation of MIF production and cell proliferation. J Immunol (1972) 1.62

Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med (1994) 1.60

Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber Lung Dis (1999) 1.57

Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction. J Exp Med (1975) 1.57

Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature (1986) 1.56

Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol (1986) 1.55

An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci U S A (1997) 1.55

Induction of cell-mediated immunity to Mycobacterium leprae in guinea pigs. Infect Immun (1979) 1.54

Isolation and characterization of the highly immunogenic cell wall-associated protein of Mycobacterium leprae. J Immunol (1989) 1.54